Complications of botulinum toxin injection for masseter hypertrophy: Incidence rate from 2036 treatments and summary of causes and preventions

J Cosmet Dermatol. 2018 Feb;17(1):33-38. doi: 10.1111/jocd.12473. Epub 2017 Dec 18.

Abstract

Background: Masseter hypertrophy is a common, prominent feature in many Asian patients, and correction procedures are often requested for esthetic reasons. Toxin masseter injections have a high efficacy and safety profile, but the risks of a variety of side effects or complications remain.

Objectives: The categorization of various complications was based on etiology, with a presentation of the author's own incidence rates for consideration and comparison.

Methods: Six hundred and eighty patients received a total of 2036 sessions of toxin injection for masseter hypertrophy from 2011 to 2016, and complications or complaints were recorded through follow-up on a by-treatment basis. Complications were grouped together based on etiology and discussed.

Results: Of 2036 sessions, temporary mastication force decrease was reported after 611 (30%), bruising after 51 (2.5%), headaches after 12 (0.58%), smile limitation after 3 (0.15%), paradoxical bulging after 10 (0.49%), sunken cheeks (subzygomatic volume loss) after 9 (0.44%), and sagging after 4 (0.20%).

Conclusions: Masseter injections remain very safe. To further decrease the incidence rate, injections should only be inside the recommended safety zone, a quadrilateral within the muscle that avoids most important local structures. Keeping injections inside the safe zone, and ideally in 3-4 different locations at least 1 cm from any border, is crucial for the prevention of complications.

Keywords: botulinum toxin injection; complications; incidence rate; masseter hypertrophy; masseter prominence; prevention.

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / administration & dosage
  • Botulinum Toxins, Type A / adverse effects*
  • Cohort Studies
  • Facial Paralysis / chemically induced
  • Facial Paralysis / physiopathology
  • Female
  • Follow-Up Studies
  • Headache / chemically induced
  • Headache / physiopathology
  • Humans
  • Hypertrophy / pathology
  • Injections, Intramuscular
  • Male
  • Masseter Muscle / abnormalities
  • Masseter Muscle / drug effects*
  • Masseter Muscle / pathology*
  • Middle Aged
  • Patient Safety
  • Retrospective Studies
  • Risk Assessment
  • Treatment Outcome
  • Trismus / chemically induced*
  • Trismus / physiopathology
  • Xerostomia / chemically induced*
  • Xerostomia / physiopathology

Substances

  • Botulinum Toxins, Type A

Supplementary concepts

  • Masticatory Muscles, Hypertrophy of